$198.40
0.05[0.03%]
At close: Apr 26
$198.40
0[0.00%]
After Hours: 4:00PM EDT
Laboratory Corp: Insider buying and selling updated today.
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
---|---|---|---|---|---|---|---|---|---|---|
Apr 03, 2024 | Mark S Schroeder | EVP, PRES DIAGNOSTICS & COO | -6.477K | $217.29 | -$1.41M | SELL | -56.26% | 5.0361426K | Apr 01 | View |
Apr 03, 2024 | Amy B Summy | EVP, CHIEF MARKETING OFFICER | -3.5K | $217.29 | -$760.51K | SELL | -46.82% | 3.975K | Apr 01 | View |
Mar 29, 2024 | Sandra D. van der Vaart | EVP, CHIEF LEGAL OFFICER | 0 | $216.67 | -$1.33M | SELL-OPTIONS | 0.00% | 7.636979K | Mar 27 - Mar 28 | View |
Mar 11, 2024 | Mark S Schroeder | EVP, PRES DIAGNOSTICS & COO | -2.929K | $167.77 | -$854.62K | SELL | -36.77% | 5.0361426K | Mar 07 | View |
Mar 11, 2024 | Amy B Summy | EVP, CHIEF MARKETING OFFICER | -227 | $218.45 | -$49.59K | SELL | -5.56% | 3.859K | Mar 07 | View |
Feb 22, 2024 | Glenn A Eisenberg | CHIEF FINANCIAL OFFICER, EVP | -20.45K | $189.80 | -$5.15M | SELL | -46.43% | 23.595K | Feb 21 | View |
Feb 22, 2024 | Jonathan P DiVincenzo | EVP, PRES, CENTRAL LABS & INTL | -500 | $215.49 | -$107.75K | SELL | -12.82% | 3.4005491K | Feb 21 | View |
Feb 15, 2024 | Sandra D. van der Vaart | EVP, CHIEF LEGAL OFFICER | -237 | $226.45 | -$53.67K | SELL | -3.01% | 7.636979K | Feb 13 | View |
Feb 09, 2024 | Sandra D. van der Vaart | EVP, CHIEF LEGAL OFFICER | -259 | $222.06 | -$57.51K | SELL | -3.28% | 7.636979K | Feb 08 | View |
Feb 06, 2024 | Sandra D. van der Vaart | EVP, CHIEF LEGAL OFFICER | 0 | $220.83 | -$58.30K | SELL-OPTIONS | 0.00% | 7.636979K | Feb 02 - Feb 05 | View |
Nov 20, 2023 | Peter J Wilkinson | SVP, CHIEF ACCOUNTING OFFICER | -1.384K | $210.71 | -$291.63K | SELL | -39.87% | 2.0872194K | Nov 16 | View |
Aug 10, 2023 | Kerrii B Anderson | DIRECTOR | -5K | $211.57 | -$1.06M | SELL | -24.49% | 15.419K | Aug 08 | View |
Jul 03, 2023 | Sandra D. van der Vaart | EVP, CHIEF LEGAL OFFICER | -212 | $240.00 | -$50.88K | SELL | -2.71% | 7.6046975K | Jun 29 | View |
May 23, 2023 | Paul R Kirchgraber | CEO, COVANCE DRUG DEVELOPMENT | 0 | $199.71 | -$147.91K | SELL-OPTIONS | 0.00% | 12.946K | May 19 | View |
May 22, 2023 | Mark S Schroeder | EVP, PRES DIAGNOSTICS & COO | 0 | $173.69 | -$129.25K | SELL-OPTIONS | 0.00% | 6.6874022K | May 18 | View |
Apr 03, 2023 | Mark S Schroeder | EVP, PRESIDENT-DIAGNOSTICS LAB | 0 | $225.34 | -$1.52M | GRANT | 0.00% | 6.6874022K | Mar 30 - Mar 31 | View |
Feb 23, 2023 | Paul R Kirchgraber | CEO, COVANCE DRUG DEVELOPMENT | -5K | $216.55 | -$1.46M | SELL | -35.54% | 9.069K | Feb 21 | View |
Feb 16, 2023 | Mark S Schroeder | EVP, PRESIDENT-DIAGNOSTICS LAB | -309 | $247.63 | -$76.52K | SELL | -4.42% | 6.6874022K | Feb 14 | View |
Feb 09, 2023 | Sandra D. van der Vaart | EVP, CHIEF LEGAL OFFICER | -219 | $243.01 | -$53.22K | SELL | -3.94% | 5.340759200000001K | Feb 07 | View |
Browse insider trades on all stocks.